Impact of sarcopenia on the risk of advanced colorectal neoplasia. Issue 1 (25th June 2018)

• Record Type: Journal Article
• Authors: Hong, Ji Taek; Kim, Tae Jun; Pyo, Jeung Hui; Kim, Eun Ran; Hong, Sung Noh; Kim, Young‐Ho; Ahn, Hyeon Seon; Sohn, Insuk; Chang, Dong Kyung
• Is Part Of: Journal of gastroenterology and hepatology. Volume 34:Issue 1(2019)
• Page Start: 162
• Page End: 168
• Publication Date: 2018-06-25
• Subjects: advanced colorectal neoplasia -- obesity -- risk factor -- sarcopenia; Gastroenterology -- Periodicals; Digestive organs -- Diseases -- Periodicals; Liver -- Diseases -- Periodicals; Gastroenterology -- Periodicals; Liver Diseases -- Periodicals; 616.33
• DOI: 10.1111/jgh.14309
• Languages: English
• ISSNs: 0815-9319

Abstract

Abstract: Background and Aim: Sarcopenia is a pathological condition characterized by the progressive loss of muscle mass and increased amount of visceral fat. Recent evidence has revealed that sarcopenia is associated with certain diseases. However, the impact of sarcopenia on colorectal neoplasia has not been documented clearly. We studied the association between sarcopenia and advanced colorectal neoplasia in a large screening population. Methods: This cross‐sectional study included 14 024 asymptomatic adults who underwent first‐time screening colonoscopy. Sarcopenia (class II) was defined as an appendicular skeletal muscle mass (ASM)/bodyweight (%) value more than two standard deviations below the mean for healthy young adults. ASM was estimated using bioelectrical impedance analysis. Results: In a multivariable model adjusted for age, sex, obesity (body mass index ≥ 25), smoking status, alcohol intake, regular exercise, and family history of colorectal cancer, the odds ratio (OR) for advanced colorectal neoplasia on comparing participants with sarcopenia (class II) to those without sarcopenia (class I + II) was 1.52 (95% confidence interval [CI], 1.23–1.86). Further adjustment for metabolic parameters attenuated this association, but the association was still significant (OR, 1.34; 95% CI, 1.07–1.68). Furthermore, the multivariable (traditional risk factors)‐adjusted OR associated with a 1% decrease on the introduction of ASM/weight% as a continuous variable in regression models was 1.04 (95% CI, 1.01–1.07) for advanced colorectal neoplasia. Conclusions: Our findings indicate that sarcopenia is significantly and progressively associated with the risk of advanced colorectal neoplasia. This association might be explained by metabolic factors that could be potential mediators of the effect of sarcopenia.